Arrieta-Villegas Claudia, Infantes-Lorenzo José Antonio, Bezos Javier, Grasa Miriam, Vidal Enric, Mercader Irene, Singh Mahavir, Domingo Mariano, de Juan Lucía, Pérez de Val Bernat
IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus Universitat Autònoma de Barcelona, Barcelona, Spain.
Servicio de Inmunología Microbiana, Centro Nacional de Microbiología, Instituto de Investigación Carlos III, Madrid, Spain.
Front Vet Sci. 2020 Jul 3;7:374. doi: 10.3389/fvets.2020.00374. eCollection 2020.
Current eradication strategies of tuberculosis (TB) in goats mainly rely on the single intradermal tuberculin test (SIT) and single intradermal cervical comparative tuberculin tests (SICCTs). TB vaccination has been proposed as a cost-effective option in high-prevalence herds or countries where economic compensation for the slaughter of positive animals is not affordable. However, TB vaccination compromises the efficiency of tuberculin-based diagnostic tests. In this study, the performance of a new diagnostic platform, based on the P22 antigenic complex, was assessed for skin test (ST), interferon-gamma release assay (IGRA), and serology under different TB scenarios. The sensitivity (Se) of diagnostic tests was assessed in TB-infected goats from the same farm (herd A, = 77). The specificity (Sp) was assessed in two TB-negative farms (both vaccinated against paratuberculosis): one TB unvaccinated (herd B, = 77) and another vaccinated with bacille Calmette-Guérin (BCG) (herd C, = 68). The single (s) P22-IGRA showed the highest Se among IGRA tests (91%), and the comparative (c) P22-ST showed the highest Sp (100% in herd B and 98% in herd C). Combined interpretation of techniques enabled the best diagnostic performances. Combining the SICCT + sP22-IGRA improved Se (97%) compared to SICCT + tuberculin-based IGRA (95%), with a reduction of Sp (95 and 100%, respectively). Besides, combination of P22-ELISA with cP22-ST or SICCT elicited a similar performance in the non-vaccination context (Se: 94 and 95%; Sp: 95 and 95%, respectively), but Sp was significantly higher for the combination with cP22-ST compared to SICCT in the TB vaccination context (95 and 79%, respectively). The combination of serological tests based on P22 and MPB83 showed higher complementarity and improved 13 percentage points the Se of P22-ELISA alone. These findings suggest that either cell-mediated or antibody-based diagnostic techniques, using the P22 antigen complex, can contribute to improve the immunodiagnostics of TB in goats under different TB control strategies.
目前山羊结核病(TB)的根除策略主要依赖于单次皮内结核菌素试验(SIT)和单次皮内颈部比较结核菌素试验(SICCT)。在高流行率的畜群或无法承担对阳性动物进行屠宰经济补偿的国家,结核病疫苗接种已被提议作为一种具有成本效益的选择。然而,结核病疫苗接种会影响基于结核菌素的诊断测试的效率。在本研究中,评估了一种基于P22抗原复合物的新型诊断平台在不同结核病情况下用于皮肤试验(ST)、干扰素-γ释放试验(IGRA)和血清学检测的性能。在来自同一养殖场的结核病感染山羊(畜群A,n = 77)中评估诊断测试的敏感性(Se)。在两个结核病阴性养殖场(均接种了副结核病疫苗)中评估特异性(Sp):一个未接种结核病疫苗(畜群B,n = 77),另一个接种了卡介苗(BCG)(畜群C,n = 68)。单次(s)P22-IGRA在IGRA测试中显示出最高的Se(91%),比较性(c)P22-ST显示出最高的Sp(畜群B中为100%,畜群C中为98%)。技术的联合解读实现了最佳诊断性能。与SICCT + 基于结核菌素的IGRA(95%)相比,SICCT + sP22-IGRA提高了Se(97%),但Sp有所降低(分别为95%和100%)。此外,在未接种疫苗的情况下,P22-ELISA与cP22-ST或SICCT联合使用表现出相似的性能(Se:94%和95%;Sp:95%和95%),但在结核病疫苗接种情况下,与cP22-ST联合使用时的Sp显著高于与SICCT联合使用时的Sp(分别为95%和79%)。基于P22和MPB83的血清学检测联合使用显示出更高的互补性,单独使用P22-ELISA时的Se提高了13个百分点。这些发现表明,使用P22抗原复合物的细胞介导或基于抗体的诊断技术,均可有助于在不同结核病控制策略下改善山羊结核病的免疫诊断。